BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 17003348)

  • 1. Imaging docking and fusion of insulin granules induced by antidiabetes agents: sulfonylurea and glinide drugs preferentially mediate the fusion of newcomer, but not previously docked, insulin granules.
    Nagamatsu S; Ohara-Imaizumi M; Nakamichi Y; Kikuta T; Nishiwaki C
    Diabetes; 2006 Oct; 55(10):2819-25. PubMed ID: 17003348
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin exocytosis in Goto-Kakizaki rat beta-cells subjected to long-term glinide or sulfonylurea treatment.
    Kawai J; Ohara-Imaizumi M; Nakamichi Y; Okamura T; Akimoto Y; Matsushima S; Aoyagi K; Kawakami H; Watanabe T; Watada H; Kawamori R; Nagamatsu S
    Biochem J; 2008 May; 412(1):93-101. PubMed ID: 18254725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIRF imaging of docking and fusion of single insulin granule motion in primary rat pancreatic beta-cells: different behaviour of granule motion between normal and Goto-Kakizaki diabetic rat beta-cells.
    Ohara-Imaizumi M; Nishiwaki C; Kikuta T; Nagai S; Nakamichi Y; Nagamatsu S
    Biochem J; 2004 Jul; 381(Pt 1):13-8. PubMed ID: 15128287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking and fusion of insulin secretory granules in SUR1 knock out mouse beta-cells observed by total internal reflection fluorescence microscopy.
    Kikuta T; Ohara-Imaizumi M; Nakazaki M; Nishiwaki C; Nakamichi Y; Tei C; Aguilar-Bryan L; Bryan J; Nagamatsu S
    FEBS Lett; 2005 Mar; 579(7):1602-6. PubMed ID: 15757648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphological localisation of sulfonylurea receptor 1 in endocrine cells of human, mouse and rat pancreas.
    Guiot Y; Stevens M; Marhfour I; Stiernet P; Mikhailov M; Ashcroft SJH; Rahier J; Henquin JC; Sempoux C
    Diabetologia; 2007 Sep; 50(9):1889-1899. PubMed ID: 17593344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glinide, but not sulfonylurea, can evoke insulin exocytosis by repetitive stimulation: imaging analysis of insulin exocytosis by secretagogue-induced repetitive stimulations.
    Aoyagi K; Ohara-Imaizumi M; Nishiwaki C; Nakamichi Y; Nagamatsu S
    Exp Diabetes Res; 2009; 2009():278762. PubMed ID: 20069052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mitiglinide (KAD-1229)].
    Kusama H; Shibata N
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():559-65. PubMed ID: 12387051
    [No Abstract]   [Full Text] [Related]  

  • 8. Variations in tissue selectivity amongst insulin secretagogues: a systematic review.
    Abdelmoneim AS; Hasenbank SE; Seubert JM; Brocks DR; Light PE; Simpson SH
    Diabetes Obes Metab; 2012 Feb; 14(2):130-8. PubMed ID: 21923736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of syntaxin-1 and SNAP-25 clusters with docking and fusion of insulin granules analysed by total internal reflection fluorescence microscopy.
    Ohara-Imaizumi M; Nishiwaki C; Nakamichi Y; Kikuta T; Nagai S; Nagamatsu S
    Diabetologia; 2004 Dec; 47(12):2200-7. PubMed ID: 15647897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin secretory granule is the major site of K(ATP) channels of the endocrine pancreas.
    Geng X; Li L; Watkins S; Robbins PD; Drain P
    Diabetes; 2003 Mar; 52(3):767-76. PubMed ID: 12606519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nateglinide and mitiglinide, but not sulfonylureas, induce insulin secretion through a mechanism mediated by calcium release from endoplasmic reticulum.
    Shigeto M; Katsura M; Matsuda M; Ohkuma S; Kaku K
    J Pharmacol Exp Ther; 2007 Jul; 322(1):1-7. PubMed ID: 17409272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glibenclamide-induced apoptosis is specifically enhanced by expression of the sulfonylurea receptor isoform SUR1 but not by expression of SUR2B or the mutant SUR1(M1289T).
    Hambrock A; de Oliveira Franz CB; Hiller S; Osswald H
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1031-7. PubMed ID: 16306272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of sulfonylurea receptor type 1 subunits of ATP-sensitive potassium channels in myocardial ischemia/reperfusion injury.
    Elrod JW; Harrell M; Flagg TP; Gundewar S; Magnuson MA; Nichols CG; Coetzee WA; Lefer DJ
    Circulation; 2008 Mar; 117(11):1405-13. PubMed ID: 18316485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
    Remedi MS; Nichols CG
    PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic exposure to tolbutamide and glibenclamide impairs insulin secretion but not transcription of K(ATP) channel components.
    Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
    Pharmacol Res; 2004 Jul; 50(1):41-6. PubMed ID: 15082027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular ATP-sensitive K+ channels in mouse pancreatic beta cells: against a role in organelle cation homeostasis.
    Varadi A; Grant A; McCormack M; Nicolson T; Magistri M; Mitchell KJ; Halestrap AP; Yuan H; Schwappach B; Rutter GA
    Diabetologia; 2006 Jul; 49(7):1567-77. PubMed ID: 16752175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel rapid- and short-acting hypoglycemic agent, a calcium(2s)-2-benzyl-3-(cis-hexahydro-2-isoindolinylcarbonyl) propionate (KAD-1229) that acts on the sulfonylurea receptor: comparison of effects between KAD-1229 and gliclazide.
    Ohnota H; Koizumi T; Tsutsumi N; Kobayashi M; Inoue S; Sato F
    J Pharmacol Exp Ther; 1994 May; 269(2):489-95. PubMed ID: 8182516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuciferine stimulates insulin secretion from beta cells-an in vitro comparison with glibenclamide.
    Nguyen KH; Ta TN; Pham TH; Nguyen QT; Pham HD; Mishra S; Nyomba BL
    J Ethnopharmacol; 2012 Jul; 142(2):488-95. PubMed ID: 22633982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the bipartite model of the sulfonylurea receptor binding site: binding of A-, B-, and A + B-site ligands.
    Winkler M; Stephan D; Bieger S; Kühner P; Wolff F; Quast U
    J Pharmacol Exp Ther; 2007 Aug; 322(2):701-8. PubMed ID: 17495126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorescence microscopy studies with a fluorescent glibenclamide derivative, a high-affinity blocker of pancreatic beta-cell ATP-sensitive K+ currents.
    Zünkler BJ; Wos-Maganga M; Panten U
    Biochem Pharmacol; 2004 Apr; 67(8):1437-44. PubMed ID: 15041461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.